Why Does Arthritis Reappear After Cancer Immunotherapy?
Mental Health

Why Does Arthritis Reappear After Cancer Immunotherapy?

By Lucas Sheridan · · 3 min read

Why Does Arthritis Reappear After Cancer Immunotherapy? A Study Explains the

Patients undergoing immunotherapy for cancer can face an unexpected complication: joint inflammation. Symptoms include swollen hands that make opening jars or turning doorknobs difficult, and knee swelling that hampers walking. While some patients experience a temporary reduction in pain and swelling, there is a risk of a severe flare that may require stopping the immunotherapy. Sang Taek Kim, associate professor of medicine (rheumatology, allergy, and immunology) at Yale School of Medicine, notes that about 20% to 25% of cancer patients will experience rheumatologic adverse events after immunotherapy. To understand why inflammation returns, Kim and colleagues examined what changed inside the joints between the first and second flare. In a study published in Cancer Immunology Research, the team discovered that certain immune cell groups present during the first flare increased in number by the time of the second flare.

This pattern suggests that during the second recurrence of inflammatory arthritis, the immune system may be reactivating memory of the previous response. „When our immune system encounters the same antigens again, those responses can become more intense,” explains Kim, who leads Yale’s Program for Immunotherapy Adverse Events in Rheumatology. The researchers focused on patients who had received immune checkpoint inhibitors, a class of immunotherapy drugs that lift restrictions on T cells, allowing them to attack tumors more effectively. In some patients, the immune response also targets healthy tissues, including joints. The team compared synovial fluid collected from patients during the first and second episodes of arthritis.

Using single‑cell sequencing, T‑cell receptor sequencing, and flow cytometry

Using single‑cell sequencing, T‑cell receptor sequencing, and flow cytometry, the researchers examined which genes were active in individual cells and tracked the T‑cell populations that mediated joint inflammation. „We observed that CD4+ PD‑1hi CXCL13hi T cells and CD8+ effector T cells from the first flare increased in number by the second flare,” Kim reports. The results indicate that these cells may drive joint inflammation and play a role in recurrence. „Our next step is to find what triggers this recurrence,” says Kim. He plans to investigate whether these T cells, identified in joints, can also be detected in the blood. If larger studies confirm that these cells can signal a second flare before symptoms appear, a blood test could help clinicians identify patients whose arthritis is more likely to recur.

The team also wants to understand whether the cells involved in joint inflammation differ from those that fight cancer. „Our goal is to ensure patients can continue treatment uninterrupted, supporting the development of therapies that reduce joint inflammation while preserving the immune system’s ability to fight cancer,” Kim emphasizes. The research was supported by the National Institutes of Health and Yale University. The content is the sole responsibility of the authors and does not necessarily reflect the official views of the National Institutes of Health. Additional support was provided by the Rheumatology Research Foundation, the Division of Internal Medicine at MD Anderson Cancer Center, and the Wilkes Melanoma Foundation. The article „Why Does Arthritis Reappear After Cancer Immunotherapy?” first appeared on Futurity.

Leave a comment

Every comment is read before it goes live. You will see it published once approved. You can send at most 2 comments per hour.